Beaker Blog February 27, 2017
SBP President’s Lecture highlights new approach to cancer immunotherapy
One of the most promising new approaches to treating cancer is immunotherapy—redirecting the immune system to detect and destroy tumor cells. That’s the topic o...
Read more
T cells (pseudo colored pink) interacting with dendritic cells (pseudo colored green)
Beaker Blog February 24, 2017
Taking science to heart
In honor of Heart Disease Awareness Month, we interviewed heart disease researcher Peter Crawford, M.D., Ph.D. , associate professor and director of the Cardiov...
Read more
Peter Crawford, M.D., Ph.D.
Beaker Blog February 23, 2017
Your cells don’t lie (about your age)
Many scientists are searching for drugs that combat aging, not just to extend human lifespan, but to stay healthier longer, too. One potential target for future...
Read more
older people jumping on the beach
Beaker Blog February 22, 2017
Measuring heart toxicity of cancer drugs in a dish
A class of cancer drugs known as tyrosine kinase inhibitors (TKIs) are often damaging to the heart, sometimes to the degree that they can’t be used in patients....
Read more
Heart muscle cells (actin filaments in green, nuclei in blue)
Beaker Blog February 22, 2017
Understanding the diabetic heart
Daniel Kelly, M.D. , cardiologist and director of the Center for Metabolic Origins of Disease at Sanford Burnham Prebys Medical Discovery Institute in Lake Nona...
Read more
Dan Kelly with Ling Lai and Teresa Leone
Beaker Blog February 21, 2017
New collaboration will accelerate heart failure research
The national incidence of heart failure hasn’t changed for 30 years. About half of the people whose hearts fail, or become too weak to pump enough blood to supp...
Read more
heart failure treatments